BAJAJ HEALTHCARE
Quarterly Results Analysis [Mar2026]
BAJAJ HEALTHCARE Quarterly Results
| Standalone | Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹153 Cr | ₹161 Cr | ₹148 Cr | ₹149 Cr | ₹154 Cr | ₹123 Cr | ₹133 Cr | ₹132 Cr |
| Expenses | ₹130 Cr | ₹131 Cr | ₹121 Cr | ₹124 Cr | ₹143 Cr | ₹101 Cr | ₹109 Cr | ₹108 Cr |
| Operating Income | ₹23 Cr | ₹31 Cr | ₹27 Cr | ₹25 Cr | ₹12 Cr | ₹22 Cr | ₹25 Cr | ₹25 Cr |
| Other Income | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹14 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr |
| Interest | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹6 Cr | ₹6 Cr | ₹8 Cr | ₹8 Cr |
| Depreciation | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr |
| Profit Before Tax | ₹-21 Cr | ₹19 Cr | ₹16 Cr | ₹15 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹10 Cr |
| Profit After Tax | ₹-19 Cr | ₹16 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹15 Cr | ₹8 Cr | ₹8 Cr |
| EPS | ₹-5.77 | ₹5.10 | ₹3.94 | ₹3.85 | ₹3.67 | ₹4.74 | ₹2.64 | ₹2.91 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| BAJAJ HEALTHCARE | -6.5% | -19.9% | -46.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.4% | 10.8% | 10.5% |
| DIVIS LABORATORIES | 0.7% | 9.5% | 16.5% |
| CIPLA | 9.7% | 16.7% | -4.9% |
| TORRENT PHARMACEUTICALS | -2.5% | 6% | 36.2% |
| DR REDDYS LABORATORIES | 4.5% | 9.7% | 9% |
| MANKIND PHARMA | 1.4% | 18% | -1.4% |
| ZYDUS LIFESCIENCES | 5.7% | 8% | 12.1% |
| LUPIN | 1.3% | -2.8% | 10.6% |
BAJAJ HEALTHCARE Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -5.06 % |
| Y-o-Y | -0.92 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹153 Cr | -5.06 | |
| Dec2025 | ₹161 Cr | 9.00 | |
| Sep2025 | ₹148 Cr | -0.62 | |
| Jun2025 | ₹149 Cr | -3.65 | |
| Mar2025 | ₹154 Cr | 25.80 | |
| Dec2024 | ₹123 Cr | -7.74 | |
| Sep2024 | ₹133 Cr | 0.64 | |
| Jun2024 | ₹132 Cr | - | |
BAJAJ HEALTHCARE Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -26.09 % |
| Y-o-Y | 92.89 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹23 Cr | -26.09 | |
| Dec2025 | ₹31 Cr | 13.85 | |
| Sep2025 | ₹27 Cr | 9.96 | |
| Jun2025 | ₹25 Cr | 108.49 | |
| Mar2025 | ₹12 Cr | -45.67 | |
| Dec2024 | ₹22 Cr | -11.76 | |
| Sep2024 | ₹25 Cr | 0.08 | |
| Jun2024 | ₹25 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -22.12 % |
| Y-o-Y | 94.74 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 14.82% | -22.12 | |
| Dec2025 | 19.03% | 4.45 | |
| Sep2025 | 18.22% | 10.63 | |
| Jun2025 | 16.47% | 116.43 | |
| Mar2025 | 7.61% | -56.81 | |
| Dec2024 | 17.62% | -4.40 | |
| Sep2024 | 18.43% | -0.54 | |
| Jun2024 | 18.53% | - | |
BAJAJ HEALTHCARE Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹-19 Cr | Negative | |
| Dec2025 | ₹16 Cr | 29.34 | |
| Sep2025 | ₹12 Cr | 2.24 | |
| Jun2025 | ₹12 Cr | 5.03 | |
| Mar2025 | ₹12 Cr | -22.54 | |
| Dec2024 | ₹15 Cr | 79.38 | |
| Sep2024 | ₹8 Cr | 3.95 | |
| Jun2024 | ₹8 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | -12.68 % | Negative | |
| Dec2025 | 9.99 % | 18.65 | |
| Sep2025 | 8.42 % | 2.93 | |
| Jun2025 | 8.18 % | 9.07 | |
| Mar2025 | 7.5 % | -38.47 | |
| Dec2024 | 12.19 % | 94.42 | |
| Sep2024 | 6.27 % | 3.29 | |
| Jun2024 | 6.07 % | - | |
BAJAJ HEALTHCARE Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹-5.77 | Negative | |
| Dec2025 | ₹5.1 | 29.44 | |
| Sep2025 | ₹3.94 | 2.34 | |
| Jun2025 | ₹3.85 | 4.90 | |
| Mar2025 | ₹3.67 | -22.57 | |
| Dec2024 | ₹4.74 | 79.55 | |
| Sep2024 | ₹2.64 | -9.28 | |
| Jun2024 | ₹2.91 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD